Suppr超能文献

相似文献

1
Optical Control of Small Molecule-Induced Protein Degradation.
J Am Chem Soc. 2020 Feb 5;142(5):2193-2197. doi: 10.1021/jacs.9b12718. Epub 2020 Jan 23.
2
PROTAC-mediated crosstalk between E3 ligases.
Chem Commun (Camb). 2019 Feb 5;55(12):1821-1824. doi: 10.1039/c8cc09541h.
3
Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs.
Bioorg Med Chem. 2019 Jun 15;27(12):2466-2479. doi: 10.1016/j.bmc.2019.02.048. Epub 2019 Feb 22.
4
E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
SLAS Discov. 2021 Apr;26(4):484-502. doi: 10.1177/2472555220965528. Epub 2020 Nov 3.
6
Development of visible-light-activatable photocaged PROTACs.
Eur J Med Chem. 2024 Feb 5;265:116062. doi: 10.1016/j.ejmech.2023.116062. Epub 2023 Dec 16.
7
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders.
Eur J Med Chem. 2024 Feb 5;265:116041. doi: 10.1016/j.ejmech.2023.116041. Epub 2023 Dec 14.
8
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Cell Chem Biol. 2018 Jan 18;25(1):78-87.e5. doi: 10.1016/j.chembiol.2017.09.010. Epub 2017 Nov 9.
9
Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase.
Nat Commun. 2019 Jan 10;10(1):131. doi: 10.1038/s41467-018-08027-7.
10
Synthesis and Evaluation of Cereblon-Recruiting HaloPROTACs.
Chembiochem. 2023 Nov 2;24(21):e202300498. doi: 10.1002/cbic.202300498. Epub 2023 Sep 13.

引用本文的文献

1
PROTAC technology for prostate cancer treatment.
Acta Mater Med. 2025 Jan 7;4(1):99-121. doi: 10.15212/amm-2024-0075. Epub 2025 Jan 30.
2
Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs.
Commun Chem. 2025 Jul 29;8(1):218. doi: 10.1038/s42004-025-01598-9.
3
Advancing Design Strategy of PROTACs for Cancer Therapy.
MedComm (2020). 2025 Jun 25;6(7):e70258. doi: 10.1002/mco2.70258. eCollection 2025 Jul.
4
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains.
ACS Pharmacol Transl Sci. 2025 Mar 14;8(4):978-1012. doi: 10.1021/acsptsci.4c00726. eCollection 2025 Apr 11.
5
POT, an optogenetics-based endogenous protein degradation system.
Commun Biol. 2025 Mar 18;8(1):455. doi: 10.1038/s42003-025-07919-x.
6
Optogenetics with Atomic Precision─A Comprehensive Review of Optical Control of Protein Function through Genetic Code Expansion.
Chem Rev. 2025 Feb 26;125(4):1663-1717. doi: 10.1021/acs.chemrev.4c00224. Epub 2025 Feb 10.
7
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy.
Front Mol Biosci. 2024 Nov 22;11:1505255. doi: 10.3389/fmolb.2024.1505255. eCollection 2024.
8
Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions.
Drug Deliv Transl Res. 2025 Jun;15(6):1801-1827. doi: 10.1007/s13346-024-01754-z. Epub 2024 Nov 29.
9
Targeted protein degradation: advances in drug discovery and clinical practice.
Signal Transduct Target Ther. 2024 Nov 6;9(1):308. doi: 10.1038/s41392-024-02004-x.
10
Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed.
Front Genet. 2024 Jul 31;15:1434002. doi: 10.3389/fgene.2024.1434002. eCollection 2024.

本文引用的文献

1
PHOTACs enable optical control of protein degradation.
Sci Adv. 2020 Feb 21;6(8):eaay5064. doi: 10.1126/sciadv.aay5064. eCollection 2020 Feb.
2
Reversible Spatiotemporal Control of Induced Protein Degradation by Bistable PhotoPROTACs.
ACS Cent Sci. 2019 Oct 23;5(10):1682-1690. doi: 10.1021/acscentsci.9b00713. Epub 2019 Sep 17.
3
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8.
ACS Med Chem Lett. 2018 Mar 18;9(6):540-545. doi: 10.1021/acsmedchemlett.8b00011. eCollection 2018 Jun 14.
4
PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
Bioessays. 2018 Apr;40(4):e1700247. doi: 10.1002/bies.201700247. Epub 2018 Feb 23.
5
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.
Nat Chem Biol. 2018 Feb;14(2):163-170. doi: 10.1038/nchembio.2538. Epub 2017 Dec 18.
6
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
J Med Chem. 2018 Jan 25;61(2):444-452. doi: 10.1021/acs.jmedchem.7b01272. Epub 2017 Dec 19.
7
Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1.
J Med Chem. 2018 Jan 25;61(2):583-598. doi: 10.1021/acs.jmedchem.7b00635. Epub 2017 Jul 10.
8
BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment.
Mol Cell. 2017 Jul 6;67(1):5-18.e19. doi: 10.1016/j.molcel.2017.06.004. Epub 2017 Jun 29.
9
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
Chem Commun (Camb). 2017 Jul 4;53(54):7577-7580. doi: 10.1039/c7cc03879h.
10
Optochemical Control of Biological Processes in Cells and Animals.
Angew Chem Int Ed Engl. 2018 Mar 5;57(11):2768-2798. doi: 10.1002/anie.201700171. Epub 2018 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验